Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Solano

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|October 14, 2014
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCTR Parody, L Lopez-Corral, O L Godino, et al.
Bone Marrow Transplantation|June 14, 2016
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter studyR Parody, L López-Corral, O Lopez-Godino, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Frontiers in Cell and Developmental Biology|March 15, 2021
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell TherapyC Ferreras, B Pascual-Miguel, C Mestre-Durán, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Bone Marrow Transplantation|November 8, 2016
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantationM A Kharfan-Dabaja, R Parody, J Perkins, et al.
Bone Marrow Transplantation|October 12, 1999
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBTJ de la Rubia, C Martínez, C Solano, et al.
Sangre|April 1, 1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]S Brunet, A Urbano-Ispizua, C Solano, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|October 14, 2014
GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCTR Parody, L Lopez-Corral, O L Godino, et al.
Bone Marrow Transplantation|June 14, 2016
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter studyR Parody, L López-Corral, O Lopez-Godino, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Frontiers in Cell and Developmental Biology|March 15, 2021
SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell TherapyC Ferreras, B Pascual-Miguel, C Mestre-Durán, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Bone Marrow Transplantation|November 8, 2016
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantationM A Kharfan-Dabaja, R Parody, J Perkins, et al.
Bone Marrow Transplantation|October 12, 1999
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBTJ de la Rubia, C Martínez, C Solano, et al.
Sangre|April 1, 1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]S Brunet, A Urbano-Ispizua, C Solano, et al.
Pageof 16